Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001161697-25-000221
Filing Date
2025-08-08
Accepted
2025-08-08 17:00:08
Documents
1
Period of Report
2025-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 FOR 08-01-2025 form_3.html 3  
1 FORM 3 FOR 08-01-2025 form_3.xml 3 3343
  Complete submission text file 0001161697-25-000221.txt   5039
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 828 WINTER STREET SUITE 300 WALTHAM MA 02451
Business Address
Curran Daniel J. (Reporting) CIK: 0001887599 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 251199279